Your search for comorbidities returned 74 results

The American Heart Association and American Stroke Association have released an update to their 2018 guidelines for the early management of acute ischemic stroke.

Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.

In patients with connective tissue disease-associated pulmonary arterial hypertension, selexipag may reduce risk for morbidity and mortality.

Factors of US medical care were compared with those of other nations in terms of quality and length of life, morbidities, mortality outcomes, and life expectancy.

The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.

Compared with age, pulmonary hypertension, right ventricular failure, and cardiopulmonary bypass time may better predict outcomes in heart transplantation.

Investigators sought to differentiate cardiac exercise responses in patients with pulmonary arterial hypertension stratified according to established measurements of disease severity.

Researchers examined the effect of riociguat compared with placebo on the REVEAL risk score and long-term outcomes for pulmonary arterial hypertension.

The clinical outcomes of patients undergoing transcarotid transcatheter aortic valve replacement with the Edwards Sapien 3 device were examined.

Patients with heart failure of mostly ischemic etiology were found to have increased burden of mendelian cardiomyopathy variants compared with control individuals.